SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Aardvark Adventures
DAVE 218.26+2.4%Nov 28 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: ~digs who wrote (1856)12/9/2005 12:31:46 PM
From: richardred  Read Replies (2) of 7944
 
The thing I like about the company. I can get local press, right near Buffalo. I like the product mix. Selling high tech products to low tech industries.
Bad thing is. The stock is easily manipulated and not very liquid. Depending on future performance. It can turn into a good thing. Institutional ownership is low. Therefore IMO technicals will be for traders. Do to the factors, I mentioned. I believe Fundamentals will drive Institutional ownership towards this stock. Leading it higher if there continues to be quarter to quarter improvement.

I'm hoping!

BTW- I've been a long term holder of PTIE. There has been a pull back from its breakout due to factor concerning FDA approval of it's new product. All things considered. I still feel the product has a more than a good chance for approval. Considering Oxycontinen is already an approved product. IMO- The FDA focus should be on the product not easily being abused as compared to Oxycontinen.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext